Group 1 - Fujian Del Technology Co., Ltd. has completed the IPO listing guidance filing with the Fujian Securities Regulatory Bureau, marking the restart of its A-share IPO journey, with the filing accepted on January 28, 2026 [2] - Established in 2014, Fujian Del Technology specializes in fluorochemical materials and has expanded into high-end sectors such as fluorinated electronic gases, ultra-pure semiconductor wet chemicals, new energy lithium battery materials, and fluorinated high-energy materials [2] - The company provides essential materials for industries including integrated circuits, new energy, ultra-high voltage, and national defense equipment, showcasing a unique industrial technology pattern characterized by high technical, customer, investment, and product value thresholds [2] Group 2 - The restart of the IPO is seen as a reflection of the company's steady and rapid growth in operational performance and a positive outlook for future development, attracting market attention once again [2] - The move aligns with the national push for traditional industry transformation and the development of new productive forces, highlighting the expectation for technology companies to leverage capital markets to enhance and expand the high-end semiconductor fine chemical industry [3]

南财智讯1月29日电，科隆股份发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润 为-6000万元—-3000万元；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为-7200万 元—-4200万元。报告期内，公司产品结构进一步优化，摆脱对单一传统产品的过度依赖。在精细化工 产品市场，推广高附加值特种助剂与定制化产品，拓宽客户群体，订单量稳步提升；在外贸业务领域， 公司积极把握全球供应链调整机遇，巩固与传统东南亚、欧洲客户的合作，开拓其他地区市场渠道，出 口产品种类与数量均有增加。同时，公司对部分装置进行优化改造，提升运营效率，为公司向高技术含 量、绿色环保的精细化工产品方向进行战略转型，奠定了坚实的硬件与工艺基础。然而受建筑行业整体 投资放缓、市场需求持续低迷的直接影响，公司传统的建材助剂类产品销量同比出现下滑。同时，子公 司沈阳华武建筑新材料科技有限公司，其生产经营与建筑行业景气度高度绑定，报告期内销量与毛利率 同比均下降，未能达成预期利润目标，导致了公司报告期出现亏损。报告期内，预计公司的非经常性损 益金额约为1200万元，主要为单项计提坏账准备的转回、政府补助等。 ...

内容概要：草酸钙是一种成熟的化工产品，在我国已经有几十年的生产历史。2024年，我国草酸钙行业 产能增长至5.48万吨，产量增长至4.64万吨；2025年我国草酸钙行业产能约6.18万吨，产量约5.26万吨。 依托于下游陶瓷、化工、医药等传统应用领域的稳定增长，以及环保治理、电子新材料等新兴领域的拓 展，我国草酸钙行业需求量持续攀升，市场稳步拓展。2024年，我国草酸钙行业需求量4.34万吨，其 中，食品及其他草酸钙占17.74%；工业级草酸钙占82.03%；医药及电子级草酸钙占0.23%。草酸钙市场 规模7.54亿元，其中，食品及其他草酸钙占20.69%；工业级草酸钙占77.45%；医药及电子级草酸钙占 1.86%。2025年，我国草酸钙需求量4.88万吨，其中，食品及其他草酸钙占17.62%；工业级草酸钙占 81.97%；医药及电子级草酸钙占0.41%。草酸钙市场规模增长至8.56亿元，其中，食品及其他草酸钙占 20.44%；工业级草酸钙占77.69%；医药及电子级草酸钙占1.87%。 上市企业：南京试剂（833179） 相关企业：广州化学试剂厂、廊坊乾耀科技有限公司、湖北齐飞医药化工有限公司、合肥亚龙化 ...

为避免条款"纸上谈兵"，宜城市总推动建立合同履约督查机制，定期开展履约检查，确保各项条款 从"纸上"落到"地上"，切实保障职工权益。此外，由当地工会、人社部门、企业代表及职工代表共同组 成联合评估组，创新实施季度"履约回头看"制度，跟踪合同履约情况；建立三方月度会商机制，根据企 业经营状况分类制定薪酬增长标准。 经过6轮深入协商，宜城市化工行业集体合同实现多个"首次"——首次明确化工行业技能人才最低工资 标准，首次将技能等级与薪酬刚性挂钩，首次设立职业健康防护专项条款，首次将女性职工"六期"特殊 保护写入合同。 有了集体合同，精细化工园区职工获得感大幅提升。在薪酬方面，技能津贴覆盖率提升至100%，3750 名技能人才待遇得到改善；明确化工行业中级工3800元至首席技师8800元的阶梯薪酬体系，还同步建 立"技能等级认定—薪酬兑现—争议调解"全流程规范。在职业健康保障方面，市总工会牵头，联合卫 健、应急管理部门，制定一企一策职业健康监护方案；要求企业对涉毒害岗位职工建立个人动态健康档 案；推动企业经职代会核定发放每月200元～500元有毒有害保健津贴，实现100%覆盖。在女职工特殊 权益保障方面，明确女职工" ...

Group 1 - The company, Hongyang (000525), expects a loss of approximately 260 million to 390 million yuan for the fiscal year 2025, a decline of 167.00% to 200.50% compared to a profit of 388.05 million yuan in the same period last year [1] - The main reason for the performance change is the absence of significant non-recurring gains from judicial restructuring, which were present in the previous year [1] - Despite the expected loss, the company's net profit after excluding non-recurring gains is projected to improve significantly, with a decrease in losses of 54.85% to 64.98% compared to the previous year, driven by recovery in core business, improved product gross margins, and reduced financial and management expenses [1] Group 2 - The main business of Hongyang includes the production and sales of raw materials and formulations, as well as the sale of ecological fertilizers, with key products being intermediates, herbicides, insecticides, and fungicides [2] - On January 26, the company announced the approval of a proposal to issue overseas bonds, aiming to raise up to 200 million USD (or equivalent in foreign currency) to enhance its financing channels and optimize its debt structure [2] - The funds raised from the overseas bond issuance will be used for general corporate purposes, project construction, debt replacement, and to supplement working capital [2]

Core Viewpoint - The company, Meilian New Materials (300586.SZ), expects a significant loss in 2025, projecting a net loss of between 55 million to 79 million yuan, which represents a year-on-year decline of 254% to 321% [1] Group 1: Financial Projections - The company anticipates a net profit attributable to shareholders of a loss between 55 million to 79 million yuan for the year 2025 [1] - The expected non-recurring gains and losses are estimated to impact the net profit attributable to shareholders by approximately 3 million to 4.5 million yuan [1] Group 2: Reasons for Decline - The primary reasons for the year-on-year decline in performance include intense market competition and changes in demand, leading to a significant decrease in the unit price of the company's fine chemical products and a substantial drop in gross margin [1] - The company has made provisions for asset impairment based on a cautious approach due to indications of potential impairment [1]

Core Viewpoint - The company, Meilian New Materials (300586.SZ), expects a significant loss in 2025, projecting a net loss between 55 million to 79 million yuan, which represents a year-on-year decline of 254% to 321% [1] Group 1: Financial Projections - The company anticipates a net profit attributable to shareholders of a loss between 55 million to 79 million yuan for the year 2025 [1] - The expected non-recurring gains and losses are estimated to impact the net profit attributable to shareholders by approximately 3 million to 4.5 million yuan [1] Group 2: Reasons for Decline - The primary reasons for the year-on-year decline in performance include intense market competition and changes in demand, leading to a significant decrease in the unit price of the company's main fine chemical products and a substantial drop in gross margin [1] - The company has made provisions for asset impairment based on a cautious approach due to indications of potential impairment [1]

Core Viewpoint - The company, Meilian New Materials, forecasts a significant net loss for the year 2025, indicating challenges in profitability due to market conditions and asset impairment [1] Financial Performance - The projected net loss attributable to shareholders for 2025 is estimated to be between 55 million to 79 million yuan [1] - The expected net loss after deducting non-recurring gains and losses is forecasted to be between 59 million to 83 million yuan [1] - Non-recurring gains and losses are anticipated to impact the net profit attributable to shareholders by approximately 3 million to 4.5 million yuan [1] Market Conditions - The company cites intense market competition and changes in demand as key factors leading to a decline in the selling prices of its main fine chemical products [1] - There has been a significant year-on-year decrease in gross profit margin due to these market pressures [1] Asset Management - The company has adopted a cautious approach by recognizing impairment provisions for assets that show signs of impairment [1]

Core Viewpoint - The company expects a net profit loss of 55 million to 79 million yuan for the year 2025, indicating a shift from profit to loss compared to the previous year [1] Group 1: Financial Performance - The anticipated net profit loss represents a significant decline year-on-year [1] - The company's main products in fine chemicals have experienced a decrease in unit prices, leading to a substantial drop in gross profit margin compared to the previous year [1] Group 2: Market Conditions - The loss is attributed to intense market competition and changes in demand, which have adversely affected the company's financial outlook [1] Group 3: Asset Management - The company has made provisions for asset impairment based on a cautious approach due to signs of impairment in relevant assets [1]

证券代码：001358 证券简称：兴欣新材 绍兴兴欣新材股份有限公司 投资者关系活动记录表 编号：2026-001 投资者关系活动类别 √特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □电话会议 □其他： （请文字说明其他活动内容） 参与单位名称 及人员姓名 东方红资管：向仕杰 兴业证券：张勋 华安基金：辛大伟 中信证券：裘科 明毅基金：李智勇 浙江国信投资：李孟如 国泰海通证券：周志鹏 东财基金：周威 时间 2026 年 1 月 27 日、2026 年 1 月 28 日 地点 绍兴兴欣新材料股份有限公司会议室 上市公司接待 人员姓名 副总经理兼董事会秘书鲁国富先生、研发总监刘帅先生 投资者关系活动 主要内容介绍 一、公司基本情况介绍： 公司成立于2002年，公司自设立以来一直从事有机胺类精 细化学品的研发、生产与销售，产品包括哌嗪系列、酰胺系列 等，主要覆盖电子化学品、环保化学品、高分子材料、医药等 | 应用领域。经过多年的发展，公司打造了完整的哌嗪衍生物产 | | --- | | 业链，在哌嗪衍生物种类、产能及性能等方面均处于行业领先 | | 水平。 | | ...